Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo

Venugopal R. Bovilla(JSS Academy of Higher Education and Research), SubbaRao V. Madhunapantula(JSS Academy of Higher Education and Research)

Biomedicines

August 30, 2021

10.3390/biomedicines9091119

Cited by 44

Related Papers

Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivo

|Frontiers in Pharmacology|2019|71

Vitamin D3 Inhibits the Viability of Breast Cancer Cells In Vitro and Ehrlich Ascites Carcinomas in Mice by Promoting Apoptosis and Cell Cycle Arrest and by Impeding Tumor Angiogenesis

|Cancers|2023|20